Welcome!


Breaking News from the Wires
Breaking Web 2.0 news stories and press releases as they happen from our partners "PR Newswire", "Marketwire", and "BusinessWire".

Subscribe to the world's most powerful i-technology newsletters at the bottom of this page and don't miss a single breaking news story!

Etrion Corporation ("Etrion") (TSX: ETX)(OMX: ETX) and Hitachi High-Technologies Corporation ("Hitachi High-Tech") (TSE: 8036), a subsidiary of Hitachi, Ltd. ("Hitachi") today announced the planned construction of 34 megawatts ("MW") in Japan with financing arranged by Sumitomo Mitsui ...
Etrion Corporation ("Etrion") (TSX:ETX)(OMX:ETX) and Hitachi High-Technologies Corporation ("Hitachi High-Tech") (TSE:8036), a subsidiary of Hitachi, Ltd. ("Hitachi") today announced the planned construction of 34 megawatts ("MW") in Japan with financing arranged by Sumitomo Mitsui Tru...

LONDON, September 1, 2014 /PRNewswire/ --

LONDON, September 1, 2014 /PRNewswire/ --

LONDON, Sept. 1, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

NEW YORK, Sept. 1, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:   Sep. 1, 2014 02:34 PM EDT  Reads: 251

LONDON, September 1, 2014 /PRNewswire/ --

LONDON, September 1, 2014 /PRNewswire/ --

LONDON, Sept. 1, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

NEW YORK, Sept. 1, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:  Sep. 1, 2014 01:00 PM EDT

DUBLIN, Sept. 1, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the Sep. 1, 2014 11:37 AM EDT  Reads: 178

NEW YORK, Sept. 1, 2014 /PRNewswire/ --  Reportlinker.com announces that a new market research report is available in its catalogue:  Sep. 1, 2014 11:32 AM EDT  Reads: 212

DALLAS, September 1, 2014 /PRNewswire/ --

DALLAS, September 1, 2014 /PRNewswire/ --

VIENNA, September 1, 2014 /PRNewswire/ --

20140901T132300+0000 businesswire.com 20010714 20140901005201 1 urn:newsml:businesswire.com:20010714:20140901005201:1 20140901T132300+0000 20140901T132300+0000 ./NewsComponent/DescriptiveMetadata/Language Copyright Business Wire 2014 LO ...

NEW YORK, September 1, 2014 /PRNewswire/ --

NEW YORK, September 1, 2014 /PRNewswire/ --

NEW YORK, September 1, 2014 /PRNewswire/ --

NEW YORK, September 1, 2014 /PRNewswire/ --

NEW YORK, September 1, 2014 /PRNewswire/ --

NEW YORK, September 1, 2014 /PRNewswire/ --

NEW YORK, September 1, 2014 /PRNewswire/ --

NEW YORK, September 1, 2014 /PRNewswire/ --

NEW YORK, September 1, 2014 /PRNewswire/ --

NEW YORK, September 1, 2014 /PRNewswire/ --

NEW YORK, September 1, 2014 /PRNewswire/ --

NEW YORK, September 1, 2014 /PRNewswire/ --

20140901T122500+0000 businesswire.com 20010714 20140901005187 1 urn:newsml:businesswire.com:20010714:20140901005187:1 20140901T122500+0000 20140901T122500+0000 ./NewsComponent/DescriptiveMetadata/Language Copyright Business Wire 2014 LO ...

CIRENCESTER, England, September 1, 2014 /PRNewswire/ --

LONDON, September 1, 2014 /PRNewswire/ --

LONDON, September 1, 2014 /PRNewswire/ --

LUDLOW, England, September 1, 2014 /PRNewswire/ --

VIENNA, September 1, 2014 /PRNewswire/ --

BRADFORD, England, September 1, 2014 /PRNewswire/ --

BRADFORD, England, September 1, 2014 /PRNewswire/ --

BRUSSELS, Sept. 1, 2014 /PRNewswire/ -- 0700 (CEST) – regulated information -- UCB announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for VIMPAT® (lacosamide) C-V as monotherapy in the treatme...